SOPH SOPHiA GENETICS SA
Nasdaq · SEC CIK 1840706 · EDGAR
- Bought, last 12 months
- $99.0K 1 purchases by 1 insiders
- Sold, last 12 months
- $4.39M 98 sales by 10 insiders
- Filings on record
- 122 since 2026-03-20, latest 2026-09-22 16:02
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Camblong Jurgi | Executive COB, Dir | — | $2.34M |
| Xu Zhenyu | CSO | — | $725.3K |
| Menu Philippe | Chief Medical Off | — | $442.5K |
| Verma Abhimanyu | CTO | — | $240.2K |
| Muken Ross | Pres | — | $169.7K |
| CARDOZA GEORGE | CFO | $99.0K | $53.5K |
| Valente Manuela | CHRO | — | $149.1K |
| HIBBS KATHY L | Dir | — | $140.1K |
| Van Well Daan | CLO | — | $116.4K |
| Puylaert Kevin | Chief Sales Off | — | $4,608 |
Transactions 127
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2026-04-08 08:47 | 2026-04-02 | SOPH | Van Well Daan | CLO | A - Grant | $0.00 | +97.5K | 358.8K | +37% | $0 |
| DA | 2026-04-08 08:47 | 2026-04-02 | SOPH | Muken Ross | Pres | A - Grant | $0.00 | +431.2K | 703.1K | +159% | $0 |
| DA | 2026-04-08 08:47 | 2026-04-02 | SOPH | CARDOZA GEORGE | CFO | A - Grant | $0.00 | +112.9K | 297.8K | +61% | $0 |
| DA | 2026-04-08 08:47 | 2026-04-02 | SOPH | Camblong Jurgi | CEO, Dir | A - Grant | $0.00 | +431.2K | 3.73M | +13% | $0 |
| DA | 2026-04-08 08:47 | 2026-04-02 | SOPH | Menu Philippe | Chief Medical Off | A - Grant | $0.00 | +112.9K | 286.6K | +65% | $0 |
| DA | 2026-04-08 08:47 | 2026-04-02 | SOPH | Puylaert Kevin | Chief Sales Off | A - Grant | $0.00 | +56.5K | 148.9K | +61% | $0 |
| DA | 2026-04-08 08:46 | 2026-04-02 | SOPH | Valente Manuela | CHRO | A - Grant | $0.00 | +71.9K | 224.2K | +47% | $0 |
| DA | 2026-04-08 08:46 | 2026-04-02 | SOPH | Xu Zhenyu | CSO | A - Grant | $0.00 | +112.9K | 650.1K | +21% | $0 |
| DA | 2026-04-08 08:46 | 2026-04-02 | SOPH | Verma Abhimanyu | CTO | A - Grant | $0.00 | +82.1K | 207.9K | +65% | $0 |
| D | 2026-04-03 06:59 | 2026-04-02 | SOPH | Verma Abhimanyu | CTO | A - Grant | $0.00 | +82.1K | 82.1K | New | $0 |
| D | 2026-04-03 06:59 | 2026-04-02 | SOPH | Muken Ross | Pres | A - Grant | $0.00 | +431.2K | 431.2K | New | $0 |
| D | 2026-04-03 06:59 | 2026-04-02 | SOPH | Menu Philippe | Chief Medical Off | A - Grant | $0.00 | +112.9K | 112.9K | New | $0 |
| D | 2026-04-03 06:59 | 2026-04-02 | SOPH | Xu Zhenyu | CSO | A - Grant | $0.00 | +112.9K | 112.9K | New | $0 |
| D | 2026-04-03 06:59 | 2026-04-02 | SOPH | Camblong Jurgi | CEO, Dir | A - Grant | $0.00 | +431.2K | 431.2K | New | $0 |
| D | 2026-04-03 06:59 | 2026-04-02 | SOPH | Puylaert Kevin | Chief Sales Off | A - Grant | $0.00 | +56.5K | 56.5K | New | $0 |
| D | 2026-04-03 06:59 | 2026-04-02 | SOPH | CARDOZA GEORGE | CFO | A - Grant | $0.00 | +112.9K | 112.9K | New | $0 |
| D | 2026-04-03 06:58 | 2026-04-02 | SOPH | Valente Manuela | CHRO | A - Grant | $0.00 | +71.9K | 71.9K | New | $0 |
| D | 2026-04-03 06:58 | 2026-04-02 | SOPH | Van Well Daan | CLO | A - Grant | $0.00 | +97.5K | 97.5K | New | $0 |
| 2026-04-01 10:41 | 2026-03-31 | SOPH | Puylaert Kevin | Chief Sales Off | S - Sale | $4.71 | -3 | 92.4K | -0.0% | -$14.13 | |
| 2026-03-20 | 2026-03-19 | SOPH | Xu Zhenyu | CSO | S - Sale | $4.78 | -608 | 537.1K | -0.1% | -$2,906 | |
| 2026-03-20 | 2026-03-19 | SOPH | Puylaert Kevin | Chief Sales Off | S - Sale | $4.76 | -33 | 92.4K | -0.0% | -$157.08 | |
| 2026-03-20 | 2026-03-19 | SOPH | Muken Ross | Pres | S - Sale | $4.79 | -1,183 | 271.9K | -0.4% | -$5,667 | |
| 2026-03-20 | 2026-03-19 | SOPH | CARDOZA GEORGE | CFO | S - Sale | $4.79 | -774 | 184.9K | -0.4% | -$3,707 | |
| 2026-03-20 | 2026-03-19 | SOPH | Van Well Daan | CLO | S - Sale | $4.79 | -684 | 261.2K | -0.3% | -$3,276 | |
| 2026-03-20 | 2026-03-19 | SOPH | Camblong Jurgi | CEO, Dir | S - Sale | $4.77 | -4,486 | 3.30M | -0.1% | -$21.4K | |
| 2026-03-20 | 2026-03-19 | SOPH | Menu Philippe | Chief Medical Off | S - Sale | $4.79 | -608 | 173.6K | -0.3% | -$2,912 | |
| 2026-03-20 | 2026-03-19 | SOPH | Valente Manuela | CHRO | S - Sale | $4.79 | -380 | 152.4K | -0.2% | -$1,820 |
Purchase Sale Sale after option exercise All abbreviations